In order for adoptively transferred CD8+ T cells to mediate durable regression of advanced cancers, they must have sufficient longevity; as not all CD8+ T-cell differentiation subsets are capable of long-term persistence as cell-therapy T cells [1–4]. Here, CD8A is linked to cancer.